Mylan launches Advair generic at 70 percent discount in US Farhat Nasim14 Feb 2019 9:15 AM ISTThe treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
GSK's severe pediatric asthma drug wins European panel thumbs-up Ruby Khatun Khatun30 July 2018 10:00 AM ISTGlaxoSmithKline (GSK) drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with...
AstraZeneca's three in one inhaler helps COPD patients in trial Medical Dialogues Bureau30 Jan 2018 9:45 AM ISTAstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
USFDA approves GSK three-in-one drug inhaler for COPD Ruby Khatun Khatun19 Sept 2017 9:57 AM ISTGlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
Propeller Health and GSK expands digital health collaboration for Asthma and COPD Ruby Khatun Khatun28 Aug 2017 9:15 AM ISTMADISON: Propeller Health, a leading digital solution for respiratory medicine, today announced the expansion of its 2015 collaboration with GSK,...
